Suppr超能文献

纤维化间质性肺疾病患者的预后预测特征:一项回顾性队列研究

Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study.

作者信息

Wang Yuanying, Guo Ziyun, Ma Ruimin, Wang Jingwei, Wu Na, Fan Yali, Ye Qiao

机构信息

Clinical Center for Interstitial Lung Diseases, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Department of Occupational Medicine and Toxicology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

出版信息

Front Pharmacol. 2022 Jul 1;13:924754. doi: 10.3389/fphar.2022.924754. eCollection 2022.

Abstract

Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD. This retrospective cohort study included patients with fibrosing ILD who were investigated between 1 January 2015 and 30 April 2021. We recorded clinical features and outcomes to identify the possible risk factors for fibrosing progression as well as mortality. Of the 579 patients with fibrosing ILD, 227 (39.21%) met the criteria for progression. Clubbing of fingers [odds ratio (OR) 1.52, 95% confidence interval (CI) 1.03 to 2.24, = 0.035] and a high-resolution computed tomography (HRCT)-documented usual interstitial pneumonia (UIP)-like fibrotic pattern (OR 1.95, 95% CI 1.33 to 2.86, = 0.001) were risk factors for fibrosis progression. The mortality was worse in patients with PF with hypoxemia [hazard ratio (HR) 2.08, 95% CI 1.31 to 3.32, = 0.002], in those with baseline diffusion capacity of the lung for carbon monoxide (DLCO) % predicted <50% (HR 2.25, 95% CI 1.45 to 3.50, < 0.001), or in those with UIP-like fibrotic pattern (HR 1.68, 95% CI 1.04 to 2.71, < 0.001). Clubbing of fingers and an HRCT-documented UIP-like fibrotic pattern were more likely to be associated with progressive fibrosing with varied prevalence based on the specific diagnosis. Among patients with progressive fibrosing, those with hypoxemia, lower baseline DLCO% predicted, or UIP-like fibrotic pattern showed poor mortality.

摘要

关于具有进行性纤维化特征的间质性肺疾病的全貌,现有数据有限。我们调查了PF-ILD患者的患病率和预后预测特征。这项回顾性队列研究纳入了2015年1月1日至2021年4月30日期间接受调查的纤维化ILD患者。我们记录了临床特征和结局,以确定纤维化进展以及死亡的可能危险因素。在579例纤维化ILD患者中,227例(39.21%)符合进展标准。手指杵状指[比值比(OR)1.52,95%置信区间(CI)1.03至2.24,P = 0.035]和高分辨率计算机断层扫描(HRCT)记录的普通型间质性肺炎(UIP)样纤维化模式(OR 1.95,95%CI 1.33至2.86,P = 0.001)是纤维化进展的危险因素。低氧血症的PF患者死亡率更高[风险比(HR)2.08,95%CI 1.31至3.32,P = 0.002],基线肺一氧化碳弥散量(DLCO)%预测值<50%的患者(HR 2.25,95%CI 1.45至3.50,P < 0.001),或具有UIP样纤维化模式的患者(HR 1.68,95%CI 1.04至2.71,P < 0.001)。手指杵状指和HRCT记录的UIP样纤维化模式更有可能与基于特定诊断的不同患病率的进行性纤维化相关。在进行性纤维化患者中,低氧血症、较低的基线DLCO%预测值或UIP样纤维化模式的患者死亡率较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fe/9283576/e36556791efd/fphar-13-924754-g001.jpg

相似文献

1
Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study.
Front Pharmacol. 2022 Jul 1;13:924754. doi: 10.3389/fphar.2022.924754. eCollection 2022.
3
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography.
Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC.
4
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
Respir Res. 2022 Jun 25;23(1):169. doi: 10.1186/s12931-022-02094-7.
6
Outcomes and predictors of progression in progressive pulmonary fibrosis.
Ann Med. 2024 Dec;56(1):2406439. doi: 10.1080/07853890.2024.2406439. Epub 2024 Sep 23.
7
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
Respir Res. 2021 Oct 31;22(1):282. doi: 10.1186/s12931-021-01879-6.
8
Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases.
Front Pharmacol. 2021 Oct 12;12:754851. doi: 10.3389/fphar.2021.754851. eCollection 2021.
9
Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study.
Front Med (Lausanne). 2022 Nov 30;9:1024298. doi: 10.3389/fmed.2022.1024298. eCollection 2022.

引用本文的文献

3
Spatial transcriptomics identifies SPARC as a prognostic marker in interstitial lung diseases.
J Pathol. 2025 Sep;267(1):79-91. doi: 10.1002/path.6451. Epub 2025 Jul 28.
6
Outcomes and predictors of progression in progressive pulmonary fibrosis.
Ann Med. 2024 Dec;56(1):2406439. doi: 10.1080/07853890.2024.2406439. Epub 2024 Sep 23.
7
The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.
Biomolecules. 2024 Feb 20;14(3):247. doi: 10.3390/biom14030247.
8
Progressive pulmonary fibrosis in myositis-specific antibody-positive interstitial pneumonia: a retrospective cohort study.
Front Med (Lausanne). 2024 Jan 11;10:1325082. doi: 10.3389/fmed.2023.1325082. eCollection 2023.
9
Impact of HRCT pattern on six-minute walk test in patients with interstitial lung disease-An observational study.
Lung India. 2023 Sep-Oct;40(5):429-433. doi: 10.4103/lungindia.lungindia_165_23.
10
Progressive fibrotic interstitial lung disease.
J Bras Pneumol. 2023 Aug 21;49(5):e20230098. doi: 10.36416/1806-3756/e20230098. eCollection 2023.

本文引用的文献

2
Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard.
Front Med (Lausanne). 2022 Mar 21;9:864658. doi: 10.3389/fmed.2022.864658. eCollection 2022.
3
Phenotypic clusters and survival analyses in interstitial pneumonia with myositis-specific autoantibodies.
Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021047. doi: 10.36141/svdld.v38i4.11368. Epub 2022 Jan 13.
4
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.
Clin Rheumatol. 2022 Mar;41(3):783-793. doi: 10.1007/s10067-021-05964-5. Epub 2021 Nov 27.
5
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients.
Diagnostics (Basel). 2021 Oct 22;11(11):1960. doi: 10.3390/diagnostics11111960.
7
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone.
Intern Emerg Med. 2022 Apr;17(3):815-822. doi: 10.1007/s11739-021-02883-w. Epub 2021 Nov 16.
8
Lung function trajectory in progressive fibrosing interstitial lung disease.
Eur Respir J. 2022 Jun 16;59(6). doi: 10.1183/13993003.01396-2021. Print 2022 Jun.
9
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
Respir Res. 2021 Oct 31;22(1):282. doi: 10.1186/s12931-021-01879-6.
10
Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases.
Front Pharmacol. 2021 Oct 12;12:754851. doi: 10.3389/fphar.2021.754851. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验